SAN DIEGO, Calif., Oct. 4, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today announced that Kenneth Locke, PhD., Chief Scientific Officer of MediciNova, will present a company overview at the 2007 BIO InvestorForum on Wednesday, October 10, 2007 at 11:15 a.m. Pacific time. The conference is being held at The Palace Hotel in San Francisco.
